Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions
Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
Aim: To study the effectiveness and safety of empagliflozin as a preoperative preparation
tool, as well as to improve the long-term prognosis of planned percutaneous coronary
interventions in patients with type 2 diabetes
Phase:
Phase 4
Details
Lead Sponsor:
Research Institute for Complex Problems of Cardiovascular Diseases, Russia